(Q30941745)

English

Impact of cytogenetics on outcome of stem cell transplantation for acute myeloid leukemia in first remission: a large-scale retrospective analysis of data from the Japan Society for Hematopoietic Cell Transplantation

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

Impact of cytogenetics on outcome of stem cell transplantation for acute myeloid leukemia in first remission: a large-scale retrospective analysis of data from the Japan Society for Hematopoietic Cell Transplantation (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

1 reference

based on heuristic

inferred from title

stem cell transplantation

1 reference

based on heuristic

inferred from title

acute myeloid leukemia

1 reference

based on heuristic

inferred from title

Mitsune Tanimoto

14

object named as

Mitsune Tanimoto

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

Satoshi Takahashi

4

object named as

Satoshi Takahashi

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

author name string

Hiroyasu Ogawa

1

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

Kazuhiro Ikegame

2

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

Manabu Kawakami

3

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

Hisashi Sakamaki

5

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

Takahiro Karasuno

6

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

Hiroshi Sao

7

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

Yoshihisa Kodera

8

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

Noriyuki Hirabayashi

9

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

Shinichiro Okamoto

10

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

Mine Harada

11

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

Koji Iwato

12

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

Atsuo Maruta

13

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

Keisei Kawa

15

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

Japan Society for Hematopoietic Cell Transplantation

16

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

publication date

1 June 2004

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

International Journal of Hematology

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

79

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

495-500

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

Alternating v repeated postremission treatment in adult acute myelogenous leukemia: a randomized phase III study (AML6) of the EORTC Leukemia Cooperative Group.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15239403

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Influence of cytogenetic abnormalities on outcome after allogeneic bone marrow transplantation for acute myeloid leukemia in first complete remission.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15239403

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The usefulness of monitoring WT1 gene transcripts for the prediction and management of relapse following allogeneic stem cell transplantation in acute type leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/15239403

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell'Ad

1 reference

https://pubmed.ncbi.nlm.nih.gov/15239403

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Karyotype in acute myeloblastic leukemia: prognostic significance for bone marrow transplantation in first remission: a European Group for Blood and Marrow Transplantation study. Acute Leukemia Working Party of the European Group for Blood and Marro

1 reference

https://pubmed.ncbi.nlm.nih.gov/15239403

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Predictors of relapse and overall survival in Philadelphia chromosome-positive acute lymphoblastic leukemia after transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/15239403

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized comparison of DAT versus ADE as induction chemotherapy in children and younger adults with acute myeloid leukemia. Results of the Medical Research Council's 10th AML trial (MRC AML10). Adult and Childhood Leukaemia Working Parties of the

1 reference

https://pubmed.ncbi.nlm.nih.gov/15239403

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Autologous bone marrow transplant in acute myeloid leukemia in first remission

1 reference

https://pubmed.ncbi.nlm.nih.gov/15239403

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Allogeneic compared with autologous stem cell transplantation in the treatment of patients younger than 46 years with acute myeloid leukemia (AML) in first complete remission (CR1): an intention-to-treat analysis of the EORTC/GIMEMAAML-10 trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/15239403

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemotherapy compared with autologous or allogeneic bone marrow transplantation in the management of acute myeloid leukemia in first remission

1 reference

https://pubmed.ncbi.nlm.nih.gov/15239403

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic value of cytogenetic findings in adults with acute myeloid leukemia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15239403

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic factors of patients with acute myeloid leukemia (AML) allografted in first complete remission: an analysis of the EORTC-GIMEMA AML 8A trial. The European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Ma

1 reference

https://pubmed.ncbi.nlm.nih.gov/15239403

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intensive postremission chemotherapy in adults with acute myeloid leukemia. Cancer and Leukemia Group B

1 reference

https://pubmed.ncbi.nlm.nih.gov/15239403

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Autologous stem cell transplantation for acute myeloid leukemia in first remission

1 reference

https://pubmed.ncbi.nlm.nih.gov/15239403

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impact of cytogenetic abnormalities on outcome of bone marrow transplants in acute myelogenous leukemia in first remission

1 reference

https://pubmed.ncbi.nlm.nih.gov/15239403

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties

1 reference

https://pubmed.ncbi.nlm.nih.gov/15239403

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Varying intensity of postremission therapy in acute myeloid leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/15239403

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomised comparison of addition of autologous bone-marrow transplantation to intensive chemotherapy for acute myeloid leukaemia in first remission: results of MRC AML 10 trial. UK Medical Research Council Adult and Children's Leukaemia Working Par

1 reference

https://pubmed.ncbi.nlm.nih.gov/15239403

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Minimal residual disease status before allogeneic bone marrow transplantation is an important determinant of successful outcome for children and adolescents with acute lymphoblastic leukemia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15239403

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/15239403

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases

1 reference

https://pubmed.ncbi.nlm.nih.gov/15239403

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Maintenance chemotherapy prolongs remission duration in adult acute nonlymphocytic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/15239403

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1532/IJH97.03166

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30941745&oldid=2175430752"